<--- Back to Details
First PageDocument Content
Borates / Borax / Boron / Boric acid / BORAX experiments / Toxicity / Pacific Coast Borax Company / Flux
Date: 2013-04-03 09:38:48
Borates
Borax
Boron
Boric acid
BORAX experiments
Toxicity
Pacific Coast Borax Company
Flux

BORAX - Summary of Health Risks Associated with Using Borax in Artisanal and Small-Scale Gold Mining Blacksmith Institute Anne Riederer ScD, Jack Caravanos DrPH EXECUTIVE SUMMARY Borax is used as a safer alternative to e

Add to Reading List

Source URL: www.blacksmithinstitute.org

Download Document from Source Website

File Size: 452,89 KB

Share Document on Facebook

Similar Documents

Glyphosate Research Scoping Background Materials: NTP Technical Report on Toxicity Studies of Glyphosate (CAS NoAdministered in Dosed Feed to F344/N Rats and B6C3F1 Mice, NTP Toxicity Reports Series No. 16,

Glyphosate Research Scoping Background Materials: NTP Technical Report on Toxicity Studies of Glyphosate (CAS NoAdministered in Dosed Feed to F344/N Rats and B6C3F1 Mice, NTP Toxicity Reports Series No. 16,

DocID: 1vr6n - View Document

IN THIS ISSUE Chemical Reaction Reducing the use of animals in toxicity testing Watershed Moment McDonald’s announces plans to

IN THIS ISSUE Chemical Reaction Reducing the use of animals in toxicity testing Watershed Moment McDonald’s announces plans to

DocID: 1vk7D - View Document

Low Toxicity Substances If ingested: What to do: These substances are considered to be of low toxicity when ingested acutely. They may cause oral irritation and mild gastrointestinal upset but other features are unlikely

Low Toxicity Substances If ingested: What to do: These substances are considered to be of low toxicity when ingested acutely. They may cause oral irritation and mild gastrointestinal upset but other features are unlikely

DocID: 1vhFH - View Document

Risk Anulvsis, 5. No. 4, I985  Letter to the Editor Toxicity and Carcinogenic Potency Leslie Bernstein,“) Lois S. Gold,(2) Bruce N. Arnes,(’) Malcolm C. Pike,(3) and David G.

Risk Anulvsis, 5. No. 4, I985 Letter to the Editor Toxicity and Carcinogenic Potency Leslie Bernstein,“) Lois S. Gold,(2) Bruce N. Arnes,(’) Malcolm C. Pike,(3) and David G.

DocID: 1vdoU - View Document

# 3083 AGI-134, a fully synthetic α-Gal-based cancer immunotherapy that shows synergy with anti-PD-1 and favorable pre-clinical pharmacokinetic and toxicity profiles Sascha A. Kristian 1,*,#, Stephen M. Shaw 1,*, Kim Wi

# 3083 AGI-134, a fully synthetic α-Gal-based cancer immunotherapy that shows synergy with anti-PD-1 and favorable pre-clinical pharmacokinetic and toxicity profiles Sascha A. Kristian 1,*,#, Stephen M. Shaw 1,*, Kim Wi

DocID: 1vdls - View Document